Not surprised to see a management change. The deal with the largest bio-pharma in the world needs talented people to commercialize it.
From a LONG perspective this deal is HUGE. Orbimed is deferring interest payments for two years which IMO establishes the time line for when they think the AMGEN along with other contracts will start generating sufficient revenue.
Not surprised to see a management change. The deal with the...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)